T. Rowe Price Associates’s CytRx Corp CYTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-8,317
Closed -$29K 2605
2016
Q3
$29K Hold
8,317
﹤0.01% 2514
2016
Q2
$111K Sell
8,317
-3,283
-28% -$54.6K ﹤0.01% 2413
2016
Q1
$187K Hold
11,600
﹤0.01% 2305
2015
Q4
$184K Buy
11,600
+33
+0.3% +$566 ﹤0.01% 2320
2015
Q3
$164K Buy
11,567
+2,167
+23% +$36.7K ﹤0.01% 2329
2015
Q2
$210K Hold
9,400
﹤0.01% 2329
2015
Q1
$190K Sell
9,400
-2,500
-21% -$46.5K ﹤0.01% 2366
2014
Q4
$196K Hold
11,900
﹤0.01% 2368
2014
Q3
$181K Buy
11,900
+2,333
+24% +$46.1K ﹤0.01% 2373
2014
Q2
$240K Sell
9,567
-8,083
-46% -$184K ﹤0.01% 2285
2014
Q1
$370K Buy
17,650
+8,183
+86% +$290K ﹤0.01% 2050
2013
Q4
$356K Sell
9,467
-2,083
-18% -$37.9K ﹤0.01% 2068
2013
Q3
$224K Sell
11,550
-767
-6% -$11.3K ﹤0.01% 2232
2013
Q2
$148K Buy
+12,317
New +$182K ﹤0.01% 2267

Other funds holding CYTR

T. Rowe Price Associates's CYTR Position: Q4 2016 in Review

T. Rowe Price Associates sold out of CytRx Corp (CYTR) in Q4 2016, closing a stake of 8,317 shares — an estimated $29K sold.

T. Rowe Price Associates first reported a position in CYTR in Q2 2013 and held it in 14 quarters. The position peaked at $370K in Q1 2014. 73 funds tracked by Wall St. Rank hold CYTR as of Q4 2016.

  • T. Rowe Price Associates reported no remaining CytRx Corp position as of Q4 2016 after selling out during the quarter.
  • T. Rowe Price Associates sold 8,317 CytRx Corp shares in Q4 2016, an estimated $29K.
  • T. Rowe Price Associates first reported a position in CytRx Corp in Q2 2013 and held it in 14 quarters.
  • T. Rowe Price Associates's CytRx Corp position peaked at $370K in Q1 2014.
  • 73 funds tracked by Wall St. Rank held CytRx Corp as of Q4 2016.

Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.